The acquisition of DreamPharma seems to be turning into a three-way battle of Kwangdong Pharmaceutical, Ahngook Pharmaceutical and Alvogen
The acquisition of DreamPharma seems to be turning into a three-way battle of Kwangdong Pharmaceutical, Ahngook Pharmaceutical and Alvogen.
On May 20, the headquarter of stock market asked companies including JW Joongwae, Kwangdong Pharmaceutical and Ahngook Pharmaceutical to answer about the ru...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
